Overview

A Clinical Trial Evaluating the Effect of Pharmacological Ascorbate on Radiation Therapy for Pancreatic Cancer Patients

Status:
Not yet recruiting

Trial end date:
2030-12-31

Target enrollment:

Participant gender:

Summary

This is a phase 2 study testing the initial efficacy of adding pharmacological ascorbate (vitamin C) to standard radiation and chemotherapy for treatment of pancreatic cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Joseph J. Cullen

Collaborator:

Holden Comprehensive Cancer Center

Treatments:

Gemcitabine